A promising organism for the study of neurotransmitter-related behavioral and developmental phenomena is
A promising organism for the study of neurotransmitter-related behavioral and developmental phenomena is This organism is genetically and biochemically tractable and exhibits an anatomical simplicity that has allowed an extensive characterization of its embryonic and postembryonic development (Deppe et al., 1978; von Ehrenstein and Schierenberg, 1980; Sulston and Horvitz, 1977 ; E. Schierenberg and J. Sulston, personal communication) . These studies have provided a nearly complete picture of the cell lineages that give rise to the relatively simple nervous system of this organism, and a wiring diagram for the entire nervous system of the wild type is available (White et al., 1976; Albertson and Thomson, 1978; Ware et al., 1975; Ward, et al., 1975; Hall, 1978; J. White, personal communication) . A number of behavioral mutants with defects in specific lineages or in the wiring diagram have been isolated and characterized (Horvitz and Sulston, 1980; Sulston and Horvitz, 1981; Chalfie et al., 1981) . However, in relatively few cases has the molecular defect in these or any other neurological mutants been determined. Another approach to genetic studies of the nervous system in the nematode has been to isolate mutants with defects in known or suspected neurotransmitter-related functions in order to study the effects of such known specific molecular defects on the extremely well-characterized nervous system of this organism. These studies have been initiated by the isolation and behavioral, molecular, and histochemical characterization of acetylcholinesterase deficient mutants of C. elegans (Johnson et al., 1981; Culotti et al., 1981) . The behavior of acetylcholinesterase mutants and of the wild type treated with an acetylcholinesterase inhibitor provide circumstantial evidence that acetylcholine is a neurotransmitter in nematodes, as has been established by electrophysiological techniques for the anatomically similar parasitic nematode Ascaris Zumbricoides (de1 Castillo et al., 1963) .
We have undertaken here a search for possible acetylcholine receptors in the nematode with the aim of eventually extending our genetic studies to these important components of cholinergic synapses. In vertebrates, acetylcholine receptors are distinguished pharmacologically (Koelle, 1975) and physiologically (Purves, 1976) as being either nicotinic or muscarinic. The work presented here is based on the introduction of the high affinity muscarinic ligands [3H]QNB (Yamamura and Snyder, 1974a) and [3H]N-methylscopolamine (Burgermeister et al., 1978) as sensitive probes for measuring and characterizing muscarinic receptors in a variety of vertebrate systems. Muscarinic receptors have been found in great abundance in the vertebrate CNS (Yamamura et al., 1974) and in peripheral targets (Galper et al., 1977; Yamamura and Snyder, 1974b) . They exist in multiple binding states (Klein, 1980a ) likely related to a functional inhibition of adenylate cyclase (Nathanson et al., 1977) , and their concentration is regulated by cholinergic stimulation in vitro and in uiuo (reviewed Klein, 1980b) . They also have been found in advanced invertebrates such as Drosophilia (Dudai and BenBarak, 1977; Haim et al., 1979) . Results presented here, which extend our preliminary report (James et al., 1980) , indicate that nematode extracts possess acetylcholine receptors which bind the muscarinic antagonists [3H] QNB and [3H]N-methylscopolamine with high affinity. The putative muscarinic receptors are present in larvae and adults in concentrations consistent with their presumed cholinergic function in vivo. These receptors do not appear to be down regulated by treatments designed to elevate in viva cholinergic agonist levels for prolonged periods of time. Preliminary results on [3H]QNB binding levels in two classes of mutants selected for possible acetycholine receptor defects are presented. To our knowledge, this report is the first to describe receptorbinding sites for any transmitter in the nematode system.
Materials and Methods
Nematode strains. Wild-type Caenorhabditis elegans uar. Bristol was originally obtained from Brenner (1974) . Acetylcholinesterase-deficient mutations of C. elegans were ace-l (plOOO)X (Johnson et al., 1981) , ace-2 (g73)1, or ace-2 (g72)I . Strains carrying the levamisole-resistant mutations uric-29 (e1072)1, uric-63 (e384)1, uric-38 (e904)1, uric-74 (x19)1, uric-50 (e306)111, Zev-1 (x21)IV, Zeu-7 (x13)1, Zeu-8 (x15)X, Zeu-9 (x16)1, unc-22 (e66)IV, Zeu-10 (x17)1, Zeu-11 (x12)1, and uric-68 (e540)V were kindly provided by Jim Lewis (Columbia University) or by the Caenorhabditis Genetics Center in Columbia, MO (Peg Swanson, curator) .
Aldicarb-resistant mutants were isolated following mutagenesis with ethylmethane sulfonate (Brenner, 1974) of the acetylcholinesterase double mutant strain GG198 (~1000, g73). F1 adults were allowed to lay eggs on standard growth plates (Brenner, 1974) containing 100 pM Aldicarb. Most eggs hatched, but most of the FZ individuals were severely inhibited for growth and locomotion. Fz individuals that hatched and grew better and/or moved better than the norm were picked and cloned. Mutants with the most interesting phenotypes (these were of two classes: paralyzed mutants or those that moved better than the acetylcholinesterase double mutant) were used for the experiments described here. These included independently derived strains NW7, NW17, NW27, NW50, NW57, NW86, NW96, NWlOO, and NW119. Strain CB450 which carries an uric-13 mutation was included since it was also discovered to be Aldicarb resistant. A genetic and morphologic description of these mutants will be the subject of another communication (J. G. Culotti, manuscript in preparation) .
Large batches of nematodes were grown on large cake pans containing standard growth agar seeded with 5 to 10 gm of Escherichia coli. Such a plate typically yielded 2 to 5 gm wet weight of healthy nematodes. Essentially 100% pure populations of Ll and L2 stage juveniles were obtained in some cases by dissolving large populations of adult nematodes with 4% hypochlorite to release fertilized eggs developing in utero. Eggs were collected by centrifugation then incubated on NGM growth plates with E. coli for 10 to 12 hr at 20°C to allow hatching. The larvae were harvested and cleaned by standard procedures or allowed to grow at 20°C for 70 to 90 hr before harvesting as synchronous adult populations. In other instances, larvae or adults were enriched from asynchronous populations by differential settling in water and selection of slow-settling or fast-settling individuals, respectively.
For binding assays, large scale cultures were grown on NGM plates containing added E. coli OP50, harvested, cleaned according to the method of Sulston and Brenner (1974) , and stored frozen at -70°C. Crude homogenates were prepared by freeze-powdering in liquid nitrogen. Binding was monitored in freeze-powdered homogenates by incubating an aliquot containing 0.5 to 1.0 mg of protein in a l-ml solution of 50 mM sodium phosphate (pH 7.4), and 1 X 10-l" to 2 X lo- Specific binding (0) was calculated as the difference between total and nonspecific binding. Points represent the difference of the means of three separate assays for both total and nonspecific binding. Standard errors were all less than 10% of the mean for each point. Inset: Scatchard plot of specific binding.
Saturation experiments were also performed on synchronous adult populations grown from a pure population of developing embryos obtained by chlorox treatment of egg-bearing adults. These results, summarized in Table  III , show that binding levels in synchronous wild-type adult populations (9.64 + 2.35 fmol/mg of protein) are somewhat less on the average than for adult-enriched populations, possibly because fewer juveniles contaminated the synchronous populations.
For two strains we compared the concentration of [3H] N-methylscopolamine binding sites in adult-enriched populations and in juvenile populations (consisting of 100% Ll and L2 larvae). In one experiment, the wild-type adult concentration of [3H]N-methylscopolamine binding sites was 11.0 fmol/mg of protein whereas the juvenile concentration was 38.5 fmol/mg of protein. In another experiment, the concentration of [3H]N-methylscopolamine binding sites in an adult-enriched population of strain X37 was 13.0 fmol/mg of protein and the juvenile concentration was 59.9 fmol/mg of protein. Equilibrium saturation experiments are being carried out with homogeneous populations of Ll larvae to determine whether larval binding sites are qualitatively different from those of adults.
The affinity of binding sites for various cholinergic compounds was measured in equilibrium competition experiments. In these experiments, the concentration of added [3H]N-methylscopolamine was held constant and competitors were added in increasing amounts. The results, shown in Figure 4 and summarized in Table I , indicate that the [3H]N-methylscopolamine binding sites in nematode homogenates resemble, to a large extent, muscarinic acetylcholine receptors found in vertebrates (Burgermeister et al., 1978; Yamamura and Snyder; 1974a , b: Yamamura et al., 1974 . Potent, highly specific muscarinic antagonists blocked the binding of [3H]Nmethylscopolamine with Ki values in the nanomolar range. The sites showed a much lower affinity for agonists, as is the case for vertebrate receptors. The muscarinic specific drug oxotremorine was the most potent agonist tested (Ki = 1.2 X lo-" M). Competition by acetylcholine was critically dependent upon prior blockade of acetylcholinesterase by eserine and partial blockade resulted in much greater apparent Ki values. These data make it clear that [3H]N-methylscopolamine was not binding to acetylcholinesterase, an enzyme that has a high activity in nematodes (Johnson et al., 1981; Culotti et al., 1981) . The nicotinic drug most potent in blocking The acetylcholine competition was carried out on a crude homogenate of the acetylcholinesterase-deficient single mutant strain GG202 (ace-2) and it also contained 50 pM eserine sulfate. In addition to the pharmacologic specificity, we also tested the stereospecificity of the [3H]N-methylscopolamine binding sites. Competition experiments with the (+) and (-) enantiomers of benzetimide showed that the (+) enantiomer was at least loo-fold more effective a competitor than the (-) enantiomer (Fig. 5 and Table I ). This also is true of vertebrate muscarinic receptors (Beld and Ariens, 1974) .
The availability of acetylcholineqterase mutants suggested the possibility of testing whether muscarinic binding sites in the nematode may be regulated by cholinergic stimulation. Such regulation has been observed for muscarinic receptors in cultures of neuron-like cloned cells and CNS cells Siman and Klein, 1979) and also in animals treated with acetylcholinesterase inhibitors (Schiller, 1979) . If analogous regulation occurs in nematodes, then mutants that diminish acetylcholinesterase activity in viva might be expected to exhibit lower levels of muscarinic binding sites than controls. Table II shows binding levels in homogenates of 90 to 95% pure adult populations of wild-type and acetylcholinesterase-deficient mutants. Binding levels in mutants and wild type were not significantly different. Even the acetylcholinesterase double mutant GG198 (~1000, g73), which is 98% deficient in acetylcholinesterase activity , exhibited a concentration of [3H] QNB binding sites comparable to wild type. Although the results with these mutants are difficult to interpret precisely, they do suggest that down regulation in nematodes, if it occurs at all, is not as extensive as described for vertebrate cells.
A pharmacological approach designed to answer the same question was carried out by adding an exogenous acetylcholinesterase inhibitor to live worms. The inhibitor Aldicarb was chosen because of its known effectiveness in nematode systems. It induces severe developmental defects even on wild-type nematodes when used at concentrations of 0.5 to 1.0 mM ; J. G. Culotti, manuscript in preparation) , suggesting that at these concentrations maximal in viva inhibition of aces '"""l-----T a , . it should be noted that the untreated adult population may not represent the perfect control. This is because Aldicarb does not prevent egg laying and hatching, but does block morphologic development (increase in size) of the hatchees. So the population of adults left on Aldicarb for nearly 2 days laid eggs which hatched. This population was, therefore, contaminated with blocked Ll stage larvae. The apparent increase in binding levels over untreated adults (collected independently) may, therefore, reflect a degree of contamination of this adult population with these next generation larvae. This was not a problem with Aldicarbtreated larvae since these remained morphologic juveniles and there was no increased heterogeneity in the population. The concentration of binding sites in Aldicarb-treated Ll and L2 larvae was 50.5 fmol/mg of protein which was approximately equal to the concentration of binding sites in untreated Ll and L2 larvae (38.5 fmol/ mg of protein) determined in a previous experiment. These results show that little or no down regulation of [3H]QNB-binding sites occurs under conditions designed to chronically elevate in vivo concentrations of acetylcholine over a period of 2 days. In fact, if anything, receptor levels increased as a result of treatment.
Although inhibition of acetylcholinesterase activity might be expected to enhance synaptic acetylcholine levels, no proof of this assumption has been obtained. A more direct experiment was carried out by treating animals with a concentration of the putative cholinergic agonist levamisole (Lewis et al., 1980b) sufficient to induce severe contraction of the body wall musculature.
As shown in Figure 4, The resistance mutations were isolated in a strain (GG198) that already contained mutations in two genes, ace-l and ace-2, which produced a 98% deficiency in acetylcholinesterase activity . The rationale for this selection was as follows: if the developmental defect induced by Aldicarb results from the action of elevated acetylcholine levels in cholinergic synapses (possibly induced by further inhibiting the 2% residual acetylcholinesterase activity in the ace-l, ace-2 double mutant), then one way to alleviate or bypass such a defect might be to genetically alter the postsynaptic receptor. In other words, Aldicarbresistant mutants of the acetylcholinesterase double mutants might carry a compensating genetic defect in an acetylcholine receptor structural gene. Consequently, C3H]QNB or [3H]N-methylscopolamine binding levels were determined for crude homogenates of several of the Aldicarb-resistant mutants. The results summarized in Table III indicate that none of these mutants is grossly deficient in r3H]QNB binding sites, although subtle deficiencies may exist.
The second class of mutants was isolated by Brenner (1974) and by Lewis et al. 1980a ) for resistance to levamisole (a component of tetramisole).
Crude homogenates of these mutants were also assayed for [3H]N-methylscopolamine binding and the concentration of binding sites is summarized in Table III . As for the Aldicarbresistant mutants, none of the levamisole-resistant mutants exhibited gross deficiencies in the concentration of [3H]N-methylscopolamine binding sites compared with the wild type, although, once again, subtle deficiencies may exist.
Discussion
These studies show that nematodes contain sites capable of binding the highly specific muscarinic antagonists [3H]N-methylscopolamine and [3H]QNB and that these sites have pharmacological characteristics similar but not identical to vertebrate muscarinic acetylcholine receptors. One difference of possible physiological interest is the apparent lack of receptor regulation in the nematode system; mutations and pharmacological treatments expected to alter levels of cholinergic stimulation had little or no influence on receptor concentration. The data represent the first characterization of binding sites for any neurotransmitter in the nematode system, and they suggest the possibility of extending genetic analysis of cholinergic synapses in nematodes, previously focused on acetylcholinesterases, to another important molecular component.
Several lines of evidence indicate that the specific Culotti and Klein Vol. 3, No. 2, Feb. 1983 radioligand binding observed here is to muscarinic receptors. First, binding of the labeled muscarinic antagonists is saturable and shows very high affinity. The dissociation constant obtained from equilibrium experiments for scopolamine (3.7 X 10-l' M) is indistinguishable from that obtained in vertebrate neural cell lines (Burgermeister et al., 1978) . The dissociation constant of [3H]QNB, determined somewhat less accurately because of higher nonspecific binding, was about 2.5 to 4 x 10-l' M. This is equal to or only slightly higher than constants obtained for other systems (Burgermeister et al., 1978; Siman and Klein, 1979) . Second, the equilibrium determination of the dissociation constant was essentially equal to that obtained from the ratio of the kinetic rate constants (5 x 10-l' M). The forward and reverse rate constants for ["H]N-methylscopolamine binding (3 x lo6 liter/mol-set and 1.6 x 10d3/sec, respectively) also were within the range for other receptors (Burgermeister et al., 1978) . Third, the maximum number of binding sites was approximately 15 fmol/mg of protein in an asynchronous adult-enriched population whether determined with saturating levels of [3H]N-methylscopolamine or [3H]QNB, consistent with the labeling of the same sites by the two ligands. This level of sites, normalized to total protein of the organism, is about 60-to 70-fold less than the highest density of sites found in regions of the mammalian brain (Yamamura et al., 1974a) . However, it is as large as the number of sites found in neuroblastoma and neuron-like hybrid clones Shifrin and Klein, 1980) that have been used profitably to study various aspects of muscarinic receptor activity and control. It appears likely, therefore, that some cells in the nematode have high levels of muscarinic binding sites. Finally, binding of radioligands was blocked at very low doses by highly specific muscarinic antagonists. Muscarinic and mixed cholinergic agonists blocked binding at higher doses, as typically is the case for muscarinic receptor systems. The approximate Ki values for agonists were slightly higher than those seen in vertebrates.
It is known, however, that a large number of factors can specifically influence muscarinic receptor affinity for agonists without changing the properties of antagonist binding (H. R. Chin and W. L. Klein, submitted for publication; Klein, 1980a) . The sites also appear to differ pharmacologically from vertebrate muscarinic receptors by having somewhat higher sensitivity to nicotinic agents than seen, for example, in mammalian synaptosomes (Burgen et al., 1974) . Isolation and analysis of binding moieties from vertebrates and nematodes labeled with the covalent antagonist [3H]propylbenzylcholine mustard may provide more information about differences in future work.
The physiological function of muscarinic binding sites in nematodes is not established.
In preliminary work, Lewis et al. (1980b) . This is consistent with the probable synaptic function of this enzyme, which by histochemical criteria appears to be limited to regions of the animal that are rich in nervous tissue (with the exception of the pharyngeointestinal valve cells which stain in wild-type and ace-l mutants, but fail to stain in ace-2 mutants).
Since one of our long term goals is to identify receptor mutants of C. elegans, we considered it necessary to study the possible regulatory effects of internal factors such as chronic cholinergic stimulation on [3H]QNB binding levels. Chronic stimulation in vertebrates results in lowered muscarinic receptor levels reviewed Klein, 1980b ) with a concomitant change in the physical state of the receptor (H. R. Chin and W. L. Klein, submitted for publication).
In order to determine whether nematodes possess a similar regulatory mechanism for receptor levels, we initially tried two ways of chronically increasing synaptic acetylcholine levels in uiuo: one was to measure the number of [3H]QNB binding sites in acetylcholinesterase-deficient mutants, and the other was to measure [3H]QNB binding sites in animals treated with the exogenously applied acetylcholinesterase inhibitor Aldicarb. In neither case was receptor concentration lower than in controls; if anything, the Aldicarb-treated animals had a higher level of binding sites than untreated controls. Possible changes in the physical state of receptors remain to be tested.
Direct stimulation by a known concentration of agonist in vivo would allow a more rigorous approach to the question of regulation. The closest we could come to this ideal situation was to add the putative cholinergic agonist levamisole to living nematodes. Levamisole induces a hypercontraction of the body musculature of C. elegans without killing the animals, an effect that is consistent with its purported role as a cholinergic agonist (Lewis et al., 1980b) . Nevertheless, treatment of nematodes with levamisole for 32 hr led to no decrease in the number of [3H]N-methylscopolamine binding sites. Further studies will be needed to establish firmly the extent to which receptor regulatory mechanisms may exist in C. elegans. The failure to find regulatory effects as a result of prolonged agonist stimulation may indicate that nematodes have not evolved such regulatory mechanisms.
It is possible that the small size of the nematode nervous system dictates that it be hard-wired and nonplastic. On the other hand, regulatory mechanisms may exist, but we have yet to find the proper method for increasing syn- Our initial screening of mutants has not uncovered any receptor-deficient phenotypes. There could be several reasons for our failure to find receptor mutants. First of all, such mutants, if they exist, could have deficiencies too subtle to be picked up by a single determination in our assay. There is clearly enough variability in the assay from one population of worms to the next and from day to day (Table I ) that multiple determinations and statistical analysis would be required to ascertain whether a given mutant was partially deficient in muscarinic binding sites. However, a more likely reason for our failure to detect any [3H]N-methylscopolamine binding site-deficient mutants is that we have not yet assayed the right class of mutants (it is also possible that an acetylcholine receptor-deficient mutant would be inviable and, therefore, could be isolated only as a conditional mutant). Finally, the most promising mutants have been screened only for C3H]QNB or [3H]N-methylscopolamine binding levels relative to the wild type. Preliminary experiments have shown low levels of specific '"'I-cY-bungarotoxin binding sites in wild-type nematode extracts. These sites are distinct from the [3H]QNB and ["H]N-methylscopolamine binding types as determined by their specificity for various cholinergic agonists and antagonists. The possibility that one or more of the mutants is deficient in lz51-a-bungarotoxin binding sites is currently being checked.
